Quantum-Si incorporated (QSI)

US — Healthcare Sector
Peers: NRIX  SEER  HCWB  MNOV  BEAM  NTLA  EDIT  VERV  PRME  PASG  BDTX  TCRR  HARP  ALEC  HOOK  ABOS  HRTX  FIXX  RNA  CRBU  CRSP 

Automate Your Wheel Strategy on QSI

With Tiblio's Option Bot, you can configure your own wheel strategy including QSI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol QSI
  • Rev/Share 0.0189
  • Book/Share 1.3544
  • PB 1.388
  • Debt/Equity 0.0488
  • CurrentRatio 19.2382
  • ROIC -0.4236

 

  • MktCap 344976437.0
  • FreeCF/Share -0.524
  • PFCF -3.6113
  • PE -3.4027
  • Debt/Assets 0.0444
  • DivYield 0
  • ROE -0.4446

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 3
  • P/B Score 4
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation QSI Alliance Global Partners -- Buy -- $3.75 Feb. 7, 2025

News

Quantum-Si: Sell On Weak Prospects And Risk Of Further Dilution
QSI
Published: May 22, 2025 by: Seeking Alpha
Sentiment: Neutral

After mistakenly having been picked up as a quantum computing play in late 2024, shares of life sciences company, Quantum-Si, have given back most of their gains in recent months. While the company used the hype to replenish its dwindling cash balances, dilution for common shareholders has been substantial. Quantum-Si remains years behind its original business plan with an inflection point nowhere in sight. The company continues to burn substantial amounts of cash.

Read More
image for news Quantum-Si: Sell On Weak Prospects And Risk Of Further Dilution
Quantum-Si incorporated (QSI) Q1 2025 Earnings Call Transcript
QSI
Published: May 15, 2025 by: Seeking Alpha
Sentiment: Neutral

Quantum-Si incorporated (NASDAQ:QSI ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Jeff Hawkins - President and CEO Jeff Keyes - CFO Conference Call Participants Kyle Mikson - Canaccord Genuity Scott Henry - Alliance Global Partners Swayampakula Ramakanth - HC Wainwright Operator Good afternoon, everyone and thank you for joining us. Earlier today, Quantum-Si released Financial Results for the First Quarter ended March 31, 2025.

Read More
image for news Quantum-Si incorporated (QSI) Q1 2025 Earnings Call Transcript
Quantum-Si (QSI) Earnings Coverage: Complete 1Q Coverage
QSI
Published: May 15, 2025 by: 24/7 Wall Street
Sentiment: Positive

Despite beating EPS estimates in 3 of the last 4 quarters, post-earnings reactions have been mixed: +6.2% (Q4 beat), –22.0% (Q3 beat), and +3.7% (Q2 beat).

Read More
image for news Quantum-Si (QSI) Earnings Coverage: Complete 1Q Coverage
Dr. Gloria Sheynkman from the University of Virginia to Present Pioneering Research utilizing Quantum-Si's Next-Gen Protein Sequencing™ Platform in Upcoming Nature Webinar on May 15
QSI
Published: May 12, 2025 by: Business Wire
Sentiment: Neutral

BRANFORD, Conn.--(BUSINESS WIRE)--Dr. Gloria Sheynkman, University of Virginia, Presents Research utilizing Quantum-Si's Next-Gen Protein Sequencing™ Platform in Nature Webinar on 5/15.

Read More
image for news Dr. Gloria Sheynkman from the University of Virginia to Present Pioneering Research utilizing Quantum-Si's Next-Gen Protein Sequencing™ Platform in Upcoming Nature Webinar on May 15
QuantumSi Set to Report Q4 Earnings: Buy, Sell or Hold the Stock?
QSI
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive

QSI's fourth-quarter performance is expected to have benefited from year-end capital spending and new product launches despite competition and stretched valuation.

Read More
image for news QuantumSi Set to Report Q4 Earnings: Buy, Sell or Hold the Stock?

About Quantum-Si incorporated (QSI)

  • IPO Date 2020-11-13
  • Website https://www.quantum-si.com
  • Industry Biotechnology
  • CEO Mr. Jeffrey Alan Hawkins
  • Employees 149

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.